Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAciFy Cough: Morphine Sulfate for Idiopathic Pulmonary Fibrosis Cough
2019-003571-19Phase 3Unknown
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of morphine in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Change in daytime cough frequency at Day 14. Status: unknown.
02
Drugs
morphine
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2019-003571-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003571-19.